Enteral administration of HMO reduced apoptosis (TUNEL) [86] and decreased ileal cleaved caspase-3 and hypoxia-inducible factor 1α (HIF1α) protein levels [88] in a murine NEC model. This evidence concerns the gene CASP3 and necrotizing enterocolitis.